More PRNewswire
View Older Stories View Newer Stories-
JUDGE RULES IN DR. BARBARA SHARIEF'S FAVOR TO PROCEED TO TRIAL WITH HER CLAIM THAT SENATOR LAUREN BOOK MALICIOUSLY SLANDERED HER WITH STATEMENTS THAT BOOK KNEW WERE FALSE
-
T. ROWE PRICE GROUP REPORTS SECOND QUARTER 2024 RESULTS
-
Canopy Growth to Report First Quarter Fiscal 2025 Financial Results on August 9, 2024
-
United Bancorporation of Alabama, Inc. Announces Second Quarter Results
-
Pelican Energy Partners Announces Acquisition of MillenniTek, LLC
-
Newforma and AVEVA Announce Groundbreaking Integration for Enhanced Project Collaboration
-
Delta Dental of California Expands Access to DeltaVision® in Partnership with VSP® Vision Care
-
Verizon Launches Siyata SD7 As Part of Its Stocked Handset Portfolio
-
CHMP has adopted a negative opinion on lecanemab for the EU
-
GMIF2024 Innovation Summit Invites All to Gather in Shenzhen on September 27
-
Piramal Pharma Limited Announces Consolidated Results for Q1FY25
-
IGT's Gaming and Digital Business and Everi to Be Acquired Simultaneously by Apollo Funds in All-Cash Transaction
-
BE OPEN Art congratulates the winners of the Regional Art Competition in the Middle East
-
3M Delivers Strong Second-Quarter Results; Company Updates Full-Year 2024 Earnings Guidance
-
Education Cannot Wait, UNICEF and Strategic Partners Announce US$2.5 Million ECW First Emergency Response Grant During High-Level Mission to Haiti with Total ECW Funding Topping US$15.8 Million
-
ALLIANCEBERNSTEIN HOLDING L.P. ANNOUNCES SECOND QUARTER RESULTS
-
BRI Prudent Strategy Yields IDR29.90 Trillion Profit in Q2 2024
-
Hisense Ignites Sporting Passion with Big Screen Viewing from Paris
-
Portland General Electric Announces Second Quarter 2024 Results
-
Invisors named one of UK's Best Workplaces for Women™ by Great Place to Work
-
Avantor® Reports Second Quarter 2024 Results
-
Aon Reports Second Quarter 2024 Results
-
CENTENE CORPORATION REPORTS SECOND QUARTER 2024 RESULTS
-
Sanyou Bio Congratulates Eluminex Biosciences and Foreseen Biotechnology on Major Breakthroughs in Innovative Drug Project
-
LightInTheBox to Report Second Quarter 2024 Financial Results on Friday, August 2, 2024
-
Money Management Institute Announces the Finalists of 2024 MMI/Barron's Industry Awards
-
Winning Strategies: Barrichello's Formula 1 Principles in tech with SOFTSWISS
-
StakeWise Launches StakeWise V3 On Gnosis Chain, Creating Staking Marketplace And Permissionless Access To New Liquid Staking Token osGNO
-
VIDEO GAMES FUEL YOUNG ATHLETES: NIMBL SURVEY SHOWS PARENTS SPENDING OVER £500 ON GAMING GEAR
-
Cowbell Secures $60 million Series C Funding from Zurich Insurance Group to Scale Up Operations and Advance Global SME Cyber Adoption
-
Bright Scholar Schedules Unaudited Financial Results for the Third Quarter of Fiscal 2024 Ended May 31, 2024
-
Xiamen Airlines Celebrates Its 40th Anniversary
-
BC.GAME Announced as 2 Block Sponsor of Bitcoin 2024 Conference
-
Waterdrop Filter and The Water Project Partnership: Making a Difference in Communities through Access to Clean Water
-
Trina Storage Achieves Tier 1 Status for Three Consecutive Quarters by BloombergNEF
-
Grand exhibition of ancient Egyptian artifacts to open at Shanghai Museum
-
ZLB23 AT THE LEELA PALACE BENGALURU RECOGNISED AS THE BEST BAR IN INDIA AT ASIA'S 50 BEST BARS 2024
-
Masdar Partners with Endesa in €1.7 Billion Renewable Energy Transaction in Spain
-
Next Meats and Dr. Foods were both chosen as the finalists of FOODNICHE SUMMIT at Cornell Tech University in New York
-
Bybit Empowers Traders with New USDC Campaign Following EU Approval
-
Consello announces appointments of Lord Mervyn Davies, Sir Sajid Javid, Anne Finucane, Carmine Di Sibio and Frank Ryan as Senior Advisors
-
Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliary cholangitis
-
Hexagon Interim Report 1 January - 30 June 2024
-
Scania interim report January-June 2024
-
China's innovative reform agenda: providing the world an alternative path to modernization
-
AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
-
Talking Tom & Friends' Summer of Sports Event Introduces New Game Characters and Features
-
XRP Healthcare Secures Major Media Partnership with Global Exhibition Titans
-
UnionPay International Enhances European Airport Acceptance, Upgrades Payment Services for Summer Travelers
-
Enjoy the Cultures and Landscapes of Gansu, Unveil the Magnificent Silk Road with Joint Hands
